MINUCCI, SAVERIO
 Distribuzione geografica
Continente #
EU - Europa 9.991
AS - Asia 8.627
NA - Nord America 7.124
SA - Sud America 875
OC - Oceania 232
AF - Africa 172
Continente sconosciuto - Info sul continente non disponibili 10
Totale 27.031
Nazione #
US - Stati Uniti d'America 6.859
CN - Cina 4.467
DE - Germania 3.527
GB - Regno Unito 2.318
SG - Singapore 1.511
IT - Italia 1.277
BR - Brasile 702
SE - Svezia 634
HK - Hong Kong 549
RU - Federazione Russa 465
KR - Corea 378
IN - India 318
JP - Giappone 307
FR - Francia 282
TR - Turchia 256
IE - Irlanda 243
NL - Olanda 239
AU - Australia 219
TW - Taiwan 212
UA - Ucraina 208
CA - Canada 194
FI - Finlandia 151
VN - Vietnam 120
ID - Indonesia 107
ES - Italia 103
EU - Europa 86
PL - Polonia 78
TH - Thailandia 73
BE - Belgio 70
CH - Svizzera 67
AT - Austria 65
MY - Malesia 65
CI - Costa d'Avorio 60
DK - Danimarca 56
CO - Colombia 54
MX - Messico 43
GR - Grecia 40
IR - Iran 37
AR - Argentina 35
NO - Norvegia 35
EC - Ecuador 27
IQ - Iraq 27
PH - Filippine 27
PT - Portogallo 27
ZA - Sudafrica 25
BD - Bangladesh 23
PK - Pakistan 22
CL - Cile 17
CZ - Repubblica Ceca 16
EG - Egitto 15
KE - Kenya 15
RO - Romania 15
SK - Slovacchia (Repubblica Slovacca) 14
CY - Cipro 13
NZ - Nuova Zelanda 13
PE - Perù 12
AE - Emirati Arabi Uniti 11
ET - Etiopia 11
HU - Ungheria 11
SI - Slovenia 11
MO - Macao, regione amministrativa speciale della Cina 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
IL - Israele 9
JO - Giordania 9
LB - Libano 8
NG - Nigeria 8
TN - Tunisia 8
AZ - Azerbaigian 7
PY - Paraguay 7
LT - Lituania 6
MA - Marocco 6
MT - Malta 6
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
UY - Uruguay 5
BO - Bolivia 4
HR - Croazia 4
LU - Lussemburgo 4
RS - Serbia 4
AL - Albania 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
QA - Qatar 3
TZ - Tanzania 3
VI - Stati Uniti Isole Vergini 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CU - Cuba 2
CW - ???statistics.table.value.countryCode.CW??? 2
GH - Ghana 2
GT - Guatemala 2
IS - Islanda 2
Totale 27.062
Città #
Frankfurt am Main 2.696
Southend 1.897
Singapore 797
Beijing 742
Ashburn 585
Hangzhou 577
Milan 475
Hong Kong 474
Dallas 408
Seattle 366
Chandler 363
Shanghai 321
Guangzhou 242
Wilmington 241
Fairfield 238
Dublin 231
Nanjing 227
Princeton 220
Council Bluffs 181
Houston 176
Dearborn 174
Redwood City 171
Ann Arbor 163
Jacksonville 151
Woodbridge 132
Los Angeles 131
Taipei 123
Bengaluru 122
Wuhan 119
Hefei 109
Santa Clara 100
Shenyang 98
Cambridge 97
Seoul 90
Tokyo 90
Des Moines 89
Mountain View 87
Redmond 87
Changsha 84
Buffalo 82
Jakarta 81
Jinan 81
Chengdu 78
Moscow 77
New York 73
San Jose 72
Tianjin 70
Columbus 69
Boardman 67
Sakarya 66
Munich 63
Zhengzhou 61
Abidjan 60
Hanover 59
Phoenix 59
Boise 58
Cangzhou 55
São Paulo 55
The Dalles 53
Toronto 51
Warsaw 51
Istanbul 45
Nanchang 45
Serra 45
Bogotá 42
Andover 41
Fuzhou 41
Pittsburgh 39
Ottawa 37
Shenzhen 37
Nuremberg 36
Bangkok 35
London 35
Rome 35
Xian 35
Chicago 34
Somerville 34
Hanoi 33
Berlin 32
Chongqing 32
Ho Chi Minh City 32
Vienna 31
Brisbane 30
Brussels 30
Changchun 30
Hebei 29
Düsseldorf 28
Rio de Janeiro 28
Boston 27
Evanston 27
Helsinki 27
Rochester 27
Kuala Lumpur 26
Kunming 26
San Diego 26
Athens 25
Atlanta 24
Suzhou 22
Melbourne 21
Pune 21
Totale 16.365
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 4.073
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer 1.514
Blood orange juice inhibits fat accumulation in mice 1.317
Entinostat for the treatment of breast cancer 843
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors 495
Guidelines for the use and interpretation of assays for monitoring autophagy 483
A dual role for Hdac1 : oncosuppressor in tumorigenesis, oncogene in tumor maintenance 482
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner 456
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 387
Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo 359
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis 316
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis 308
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer 306
MicroRNA-222 Regulates Melanoma Plasticity 303
Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples 287
Tranylcypromine Derivatives Useful as Inhibitors Demethylases LSD1 and LSD2 266
Differentiation response of acute promyelocytic leukemia cells and PML/RAR alpha leukemogenic activity studies by real-time RT-PCR 259
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one- carbon metabolism in breast cancer 256
Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity 244
Mechanisms of selective anticancer action of histone deacetylase inhibitors 235
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 232
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer 227
Epigenomic profiling of cancer cells 221
Immunohistochemical detection of Ym1/Ym2 chitinase-like lectins associated with hyalinosis and polypoid adenomas of the transitional epithelium in a mouse with acute myeloid leukemia 215
The methyl-CpG binding protein MBD1 is required for PML-RARα function 214
PP2A Controls Genome Integrity by Integrating Nutrient-Sensing and Metabolic Pathways with the DNA Damage Response 213
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia 207
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples 206
DNA Methyl-Transferase inhibitors and Histone De-Acetylases inhibitors contrast leukemias reactivating the same apoptosis pathways 203
Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology 200
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response 200
Il succo di arancia rossa inibisce l’accumulo di grassi in modelli animali 196
New method to detect histone acetylation levels by flow cytometry 194
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation 194
Cluster assembled nanostructured TiO2 film mediates efficient and safe retroviral gene transduction in primary adult human melanocytes for ex-vivo gene therapy 193
PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samples 191
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation 191
Acetylation: a novel link between double-strand break repair and autophagy 189
HDACs link the DNA damage response, processing of double-strand breaks and autophagy 187
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice 186
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 185
Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer 184
Assessment of histone acetylation levels in relation to cell cycle phase 181
Histone deacetylases and epigenetic therapies of hematological malignancies 179
Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells 176
Chromatin accessibility, p300 and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia 175
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 175
Redox-mediated suberoylanilide hydroxamic acid sensitivity in breast cancer 173
Semantic and geographical analysis of COVID-19 trials reveals a fragmented clinical research landscape likely to impair informativeness 172
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 169
A Refined Single Cell Landscape of Haematopoiesis in the Mouse Foetal Liver 169
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion 168
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells 165
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment 164
Self-renewal of tumor cells : Epigenetic determinants of the cancer stem cell phenotype 161
The International Human Epigenome Consortium : A Blueprint for Scientific Collaboration and Discovery 160
Extensive and systematic rewiring of histone post-translational modifications in cancer model systems 160
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype 159
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses 157
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells 155
Molecular and biological analysis of histone deacetylase inhibitors with diverse specificities 155
BLUEPRINT to decode the epigenetic signature written in blood 153
Common themes in the pathogenesis of acute myeloid leukemia 151
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies 151
Sex and cancer immunotherapy: Current understanding and challenges 148
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors 147
The APL-associated fusion proteins 146
Retinoid X receptor-selective ligands produce malformations in Xenopus embryos 146
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 146
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia 145
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach 144
Determinants of oncogenic transformation in acute promyelocytic leukemia : the hetero-union makes the force 143
Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis 142
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells 142
Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation 142
Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms 142
Blueprint to decode the epigenetic signature written in blood 137
Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc 136
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 136
Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy 135
Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810 135
p66Shc-generated oxidative signal promotes fat accumulation 132
PML is required for telomere stability in non-neoplastic human cells 132
Leukemia-associated fusion proteins : multiple mechanisms of action to drive cell transformation 130
Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition 129
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor 129
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras 129
MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function 128
Eosinophilic crystals as a distinctive morphologic feature of a hyaline droplet nephropathy in a mouse model of acute myelogenous leukaemia 128
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 128
A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis 125
Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue 125
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO 120
Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication 120
Spiro[chromane-2,4'-piperidine]-based histone deacetylase inhibitors with improved in vivo activity 119
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside 118
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein 117
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway 114
Erratum: PML is required for telomere stability in non-neoplastic human cells (vol 35, pg 1811, 2016) 114
A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia 110
Totale 26.004
Categoria #
all - tutte 60.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.630 0 0 0 0 0 217 195 136 315 215 357 195
2021/20222.012 154 127 122 168 164 177 168 153 209 143 170 257
2022/20231.915 240 166 149 224 182 328 96 104 170 68 85 103
2023/20243.446 93 115 87 136 327 242 421 381 227 428 488 501
2024/20254.508 437 517 357 405 260 204 236 461 227 290 392 722
2025/20263.612 591 448 904 585 689 395 0 0 0 0 0 0
Totale 27.911